The GRASP (Global Research on Attitudes about hypertension and Stroke Prevention) survey, conducted in 11 countries and involving 825 physicians, was designed to investigate physician perceptions and priorities in the treatment of hypertension and influences on choice of antihypertensive therapy. The prevention of stroke was identified as a major priority in this survey, but there appeared to be some degree of mismatch between the evidence from large controlled trials and current patterns of prescribing for stroke prevention. The results of GRASP confirm the desirability of research to identify methods and strategies that will facilitate the integration of clinical trial results into general practice treatment of hypertension
none7noBACKGROUND: The aim of this survey was to evaluate attitudes and preferences for the clinica...
Abstract: Knowledge of guideline implementation pitfalls allows anticipation and solving of problems...
BACKGROUND: Antihypertensive medicines are effective in reducing adverse cardiovascular events. Our ...
Patient- and stakeholder-oriented research is vital to improving the relevance of research. The auth...
Introduction: Approximately 54% of strokes are attributed to high blood pressure. A survey was condu...
BACKGROUND: Hypertension is the most common treatable risk factor for stroke. Efforts have been made...
<p>Objectives: The International Society of Hypertension (ISH) surveyed trends in the management of ...
Aims: The Supporting Hypertension Awareness and Research Europe-wide (SHARE) survey aimed to qualify...
Aims: The Supporting Hypertension Awareness and Research Europe-wide (SHARE) survey aimed to qualify...
Hypertensive patients with cardiovascular (CV) comorbidities are at increased risk, and cardiologist...
OBJECTIVES. To compare family physicians' reported practice habits on hypertension in Sweden and Min...
OBJECTIVES: The Supporting Hypertension Awareness and Research Europe-wide (SHARE) physician survey ...
OBJECTIVE: To monitor changes in family physicians' reported practice on hypertension and hyperchole...
Objective: To investigate the antihypertensive prescribing patterns among physicians at KAMC-R. M...
Background: In the treatment of hypertension, physicians’ attitudes and practice patterns are receiv...
none7noBACKGROUND: The aim of this survey was to evaluate attitudes and preferences for the clinica...
Abstract: Knowledge of guideline implementation pitfalls allows anticipation and solving of problems...
BACKGROUND: Antihypertensive medicines are effective in reducing adverse cardiovascular events. Our ...
Patient- and stakeholder-oriented research is vital to improving the relevance of research. The auth...
Introduction: Approximately 54% of strokes are attributed to high blood pressure. A survey was condu...
BACKGROUND: Hypertension is the most common treatable risk factor for stroke. Efforts have been made...
<p>Objectives: The International Society of Hypertension (ISH) surveyed trends in the management of ...
Aims: The Supporting Hypertension Awareness and Research Europe-wide (SHARE) survey aimed to qualify...
Aims: The Supporting Hypertension Awareness and Research Europe-wide (SHARE) survey aimed to qualify...
Hypertensive patients with cardiovascular (CV) comorbidities are at increased risk, and cardiologist...
OBJECTIVES. To compare family physicians' reported practice habits on hypertension in Sweden and Min...
OBJECTIVES: The Supporting Hypertension Awareness and Research Europe-wide (SHARE) physician survey ...
OBJECTIVE: To monitor changes in family physicians' reported practice on hypertension and hyperchole...
Objective: To investigate the antihypertensive prescribing patterns among physicians at KAMC-R. M...
Background: In the treatment of hypertension, physicians’ attitudes and practice patterns are receiv...
none7noBACKGROUND: The aim of this survey was to evaluate attitudes and preferences for the clinica...
Abstract: Knowledge of guideline implementation pitfalls allows anticipation and solving of problems...
BACKGROUND: Antihypertensive medicines are effective in reducing adverse cardiovascular events. Our ...